Cite
HARVARD Citation
Stingeni, L. et al. (2023). A 52‐week update of a multicentre Italian real‐world experience on effectiveness and safety of dupilumab in adolescents with moderate‐to‐severe atopic dermatitis. Journal of the European Academy of Dermatology and Venereology. pp. e384-e388. [Online].